Cargando…
Arsenic-Based Antineoplastic Drugs and Their Mechanisms of Action
Arsenic-based compounds have become accepted agents for cancer therapy providing high rates of remission of some cancers such as acute promyelocytic leukemia (APL). The mechanisms by which arsenic-containing compounds kill cells and reasons for selective killing of only certain types of cancer cells...
Autor principal: | Ralph, Stephen John |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2292810/ https://www.ncbi.nlm.nih.gov/pubmed/18431449 http://dx.doi.org/10.1155/2008/260146 |
Ejemplares similares
-
Resistance to antineoplastic drugs
por: Twentyman, Peter
Publicado: (1990) -
Promising Antineoplastic Actions of Melatonin
por: Favero, Gaia, et al.
Publicado: (2018) -
Clinical Pharmacology of Antineoplastic Drugs
por: Stewart, A.
Publicado: (1979) -
Recent Trends in the Development of Novel Metal-Based Antineoplastic Drugs
por: Todorov, Lozan, et al.
Publicado: (2023) -
Therapeutic drug monitoring of oral targeted antineoplastic drugs
por: Mueller-Schoell, Anna, et al.
Publicado: (2020)